latanoprostene bunod 0.24 MG/ML Ophthalmic Solution
- RxCUI
- 1988394
- RxNorm name
- latanoprostene bunod 0.24 MG/ML Ophthalmic Solution
- Display name
- latanoprostene bunod 0.24 MG/ML Ophthalmic Solution
- Full name
- latanoprostene bunod 0.24 MG/ML Ophthalmic Solution
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:00
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Latanoprostene Bunod Ophthalmic Solution, 0.024% | LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024% | Gland Pharma Limited | 1beedfbd-5e2b-4ab1-ab8e-8320e69af1ea | 2025-05-02 | Warnings, Adverse reactions | 1988394 |
| Vyzulta | LATANOPROSTENE BUNOD | Bausch & Lomb Incorporated | 60ce7900-a677-4fc2-88d0-1603baa9dbd4 | 2024-02-27 | Warnings, Adverse reactions | 1988394 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 60ce7900-a677-4fc2-88d0-1603baa9dbd4 | latanoprostene bunod 0.024 % Ophthalmic Solution [PSN] · latanoprostene bunod 0.24 MG/ML Ophthalmic Solution [SCD] · latanoprostene bunod 0.024 % Ophthalmic Solution [SY] | 3 | 7 | These highlights do not include all the information needed to use VYZULTA safely and effectively. See full prescribing information for VYZULTA. VYZULTA ® (latanoprostene bunod ophthalmic solution) 0.024%, for topical ophthalmic use Initial U.S. Approval: 2017 | 20240227 |
| 1beedfbd-5e2b-4ab1-ab8e-8320e69af1ea | latanoprostene bunod 0.024 % Ophthalmic Solution [PSN] · latanoprostene bunod 0.24 MG/ML Ophthalmic Solution [SCD] · latanoprostene bunod 0.024 % Ophthalmic Solution [SY] | 3 | 6 | These highlights do not include all the information needed to use LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION. LATANOPROSTENE BUNOD ophthalmic solution. Initial U.S. Approval: 2017 | 20250502 |